Archives
- 2026-09
- 2026-08
- 2026-07
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-07
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
-
Caspase-3 Colorimetric Assay Kit: Practical Guide
2026-09-11
The Caspase-3 Colorimetric Assay Kit (SKU K2008) provides a practical way to measure DEVD-dependent caspase-3 activity through p-nitroaniline absorbance in compatible biological lysates. It is suited to relative apoptosis assay and caspase activity measurement workflows, but should not be used as standalone proof of apoptosis, caspase-3 exclusivity, or performance in unvalidated sample matrices.
-
BML-277: Chk2 Inhibitor for DNA Damage Research
2026-09-11
BML-277 is a Chk2 inhibitor with reported nanomolar biochemical potency and concentration-dependent rescue of irradiated human T-cell populations. Its defined ATP-site mechanism makes it useful for DNA damage response research, while direct effects on the nuclear cGAS–TRIM41 pathway remain a testable hypothesis.
-
MTT for In Vitro Cell Viability Assays
2026-09-10
MTT, or 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyl-2H-tetrazolium bromide, is a colorimetric reagent for estimating cellular metabolic activity in vitro. Its purple formazan signal is useful for comparative proliferation and cytotoxicity studies, but it is not a direct or universal measure of cell number.
-
Telatinib (BAY 57-9352) Assay Workflows
2026-09-10
Telatinib (BAY 57-9352) supports mechanism-aware studies of angiogenesis, tumor-cell proliferation, invasion, and receptor-kinase signaling. This practical guide translates its VEGFR, c-Kit, and PDGFR activity into dose design, combination testing, troubleshooting, and phenotype-focused workflows.
-
Gallein for GPCR Signaling Research
2026-09-09
Gallein is a practical G protein βγ subunit inhibitor for testing how GPCR-linked signals influence cancer invasion, macrophage polarization, cardiac remodeling, and emerging metabolic pathways. This workflow-focused guide connects validated disease-model evidence with an exploratory strategy for dissecting lactate–GPR81 signaling and insulin-independent glucose uptake.
-
Liproxstatin-1 for Ferroptosis Workflows
2026-09-09
Build cleaner ferroptosis experiments with Liproxstatin-1 as a pathway-specific rescue control, lipid-peroxidation readout partner, and GPX4-deficient cell protection tool. The workflow also shows how to distinguish ferroptosis from apoptosis, oxidative injury, and cuproptosis in cancer and renal injury studies.
-
EZ Cap™ Firefly Luciferase mRNA (m1Ψ) Workflow
2026-09-08
Build a reproducible reporter workflow that separates mRNA delivery, translation, cell health, and expression kinetics. This guide shows how to use Cap1, m1Ψ-modified Firefly Luciferase mRNA as a practical benchmark while interpreting emerging evidence on synthetic mRNA translation fidelity.
-
Resazurin Cell Viability Assay Kit: Lab Guide
2026-09-07
A practical, scenario-driven guide to selecting and optimizing the Resazurin Cell Viability Assay Kit, SKU K2234, for proliferation, cytotoxicity, and cell-health studies. It explains assay principles, compatibility, controls, data interpretation, and vendor-selection criteria while distinguishing product-supported claims from study-specific recommendations.
-
Doxorubicin hydrochloride: Practical Workflows
2026-09-07
Doxorubicin hydrochloride is a versatile tool for modeling DNA damage, tumor-cell death, and anthracycline-associated cardiac injury. This workflow-focused guide connects dose finding, apoptosis assay design, and cardiotoxicity endpoints with findings from a recent thymoquinone study.
-
DMG-PEG2000-NH2: LNP Workflow & Troubleshooting
2026-09-05
DMG-PEG2000-NH2 combines a lipid-compatible anchor, PEG2000 spacer, and reactive primary amine for controlled bioconjugation and surface engineering. This practical guide connects amide coupling, liposome and LNP formulation, siRNA encapsulation, and assay-led troubleshooting without overstating what the reference antimycobacterial study demonstrated.
-
Epinephrine Bitartrate: From Receptor Signal to Translation
2026-09-04
Epinephrine Bitartrate is more than a conventional vasoconstrictor: it is a non-selective adrenergic receptor agonist that can connect receptor pharmacology with cardiovascular disease research, sympathetic nervous system research, and translational studies of tissue-specific physiology. This article provides a mechanistic framework, experimental guidance, and evidence-aware strategies for using (-)-Epinephrine (+)-bitartrate in reproducible research programs.
-
Structured RNA, Stronger Translational Decisions
2026-09-04
RNA structure and transcript abundance can determine whether a promising biomarker is measured reliably. This thought-leadership article examines how engineered reverse transcription, using FGFR2 fusion research as a translational case study, can strengthen assay design without overstating preclinical evidence.
-
DDX3 Helicase Domain: Expression and X-ray Analysis
2026-09-04
This study established a reproducible route to express, purify, crystallize, and preliminarily characterize the human DDX3 helicase domain. The resulting 2.2 Å synchrotron diffraction data created an important structural starting point for understanding DEAD-box RNA helicase function, RNA recognition, and disease-associated interactions.
-
IL-18 Peptide Tools Reveal Caspase Specificity
2026-09-03
A 2025 bioRxiv preprint introduces LESD-based peptide probes and inhibitors derived from the IL-18 cleavage sequence, revealing unexpectedly strong activity against caspase-8 as well as inflammatory caspases. The study also shows that VX-765, commonly treated as a caspase-1 inhibitor, can inhibit caspase-8 under matched biochemical conditions, emphasizing the need for cross-caspase controls.
-
GluN2A/GluN2B Control of TMJ Inflammatory Allodynia
2026-09-02
This reference study shows that GluN2A and GluN2B in the trigeminal ganglion contribute causally to temporomandibular joint inflammation–evoked mechanical allodynia by regulating connexin- and pannexin-associated communication. Its combination of trigeminal ganglion conditional knockout, satellite glial cell experiments, behavioral testing, and pathway analysis provides a mechanistic framework for studying peripheral sensitization in orofacial pain.